Regel Therapeutics - Crunchbase Company Profile & Funding

Q: Who invested in Regel Therapeutics?

Regel Therapeutics is funded by HS Chau Foundation.

Q: How much funding has Regel Therapeutics raised to date?

Regel Therapeutics has raised obfuscated.

Overview

Regel Therapeutics

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Regel Therapeutics

CB Rank

81537

Regel Therapeutics provides gene therapy that significantly improve the lives of people with life-threatening genetic illnesses.

Founded

obfuscation

Private

Grant

Boston, Massachusetts, United States

11-50

regeltherapeutics.com/

Biotechnology

Genetics

Therapeutics

Funding Rounds

Grant

OBF

obfuscation

Key People

Stephen Farr: Chief Executive Officer
Past Role: Zogenix, President & Chief Executive Officer

Details

Legal Name

Regel Therapeutics Inc.

Also Known As

Regel

Operating Status

Active

Company Type

For Profit

About the Company

Regel Therapeutics is dedicated to revolutionizing gene therapy and transforming patient outcomes across a variety of indications by utilizing its unique platform technology.

Contact Email

info@regeltherapeutics.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Key Employee Changes

Products & Services

T3 Platform

A gene therapy platform combining AAV delivery with a programmable dCas and a regulatory element to epigenetically adjust abnormal gene expression and restrict intervention to specific cells.

RT101

A therapeutic approach developed using the T3 platform for the treatment of Dravet Syndrome, a severe form of epilepsy.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Grant - Regel Therapeutics	1	obfuscated obfuscation	HS Chau Foundation	Grant
obfuscated obfuscation	Grant - Regel Therapeutics	1	obfuscated obfuscation	HS Chau Foundation	Grant
obfuscated obfuscation	Grant - Regel Therapeutics	1	obfuscated obfuscation	HS Chau Foundation	Grant
obfuscated obfuscation	Grant - Regel Therapeutics	1	obfuscated obfuscation	HS Chau Foundation	Grant
obfuscated obfuscation	Grant - Regel Therapeutics	1	obfuscated obfuscation	HS Chau Foundation	Grant

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Grant - Regel Therapeutics	1	obfuscated obfuscation	HS Chau Foundation	Grant
obfuscated obfuscation	Grant - Regel Therapeutics	1	obfuscated obfuscation	HS Chau Foundation	Grant
obfuscated obfuscation	Grant - Regel Therapeutics	1	obfuscated obfuscation	HS Chau Foundation	Grant
obfuscated obfuscation	Grant - Regel Therapeutics	1	obfuscated obfuscation	HS Chau Foundation	Grant
obfuscated obfuscation	Grant - Regel Therapeutics	1	obfuscated obfuscation	HS Chau Foundation	Grant

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
HS Chau Foundation	Yes	Grant - Regel Therapeutics	—
HS Chau Foundation	Yes	Grant - Regel Therapeutics	—
HS Chau Foundation	Yes	Grant - Regel Therapeutics	—
HS Chau Foundation	Yes	Grant - Regel Therapeutics	—
HS Chau Foundation	Yes	Grant - Regel Therapeutics	—